Market Place
Sourcing Support
All News #Library
Biotech
Medera Completes Enrollment in MUSIC-HFpEF Phase 1/2a Trial
05 Jan 2026 //
GLOBENEWSWIRE
Medera Joins Oppenheimer Rare Disease Summit 2025
04 Dec 2025 //
GLOBENEWSWIRE
Medera Shows First-In-Human Gene Therapy Data For HFpEF
09 Nov 2025 //
GLOBENEWSWIRE
Medera Doses First Patient in Ph 2 MUSIC-HFrEF Gene Therapy Trial
27 Oct 2025 //
GLOBENEWSWIRE
Medera, Kansas University Begin DMD Gene Therapy Trial
15 Jul 2025 //
GLOBENEWSWIRE
Novoheart Joins Project on Mini-Hearts for HLHS Treatment
24 Jun 2025 //
GLOBENEWSWIRE
Medera Shows Positive Data From First-in-Human Gene Therapy Trial
19 May 2025 //
GLOBENEWSWIRE
Medera Presents Updated Results from First-In-Human Gene Therapy
01 Apr 2025 //
GLOBENEWSWIRE
Medera finishes dosing in Phase 1/2a MUSIC-HFrEF trial of SRD-001
11 Mar 2025 //
GLOBENEWSWIRE
Medera to Participate in Two Upcoming Investor Conferences
07 Feb 2025 //
GLOBENEWSWIRE
Medera & Singapore Launch Asia’s First Cardiac Gene Therapy Trial
19 Nov 2024 //
GLOBENEWSWIRE
Medera Publishes Machine Learning Drug Screening Study
31 Oct 2024 //
PR NEWSWIRE
Medera Inc. to List on NASDAQ via Merger with Keen Vision Acquisition Corp
05 Sep 2024 //
PR NEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.